TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLDAndrea Caddeo, Andrea Perra|International Journal of Molecular Sciences|2021Cited by 77
Estrogen-dependent TRX2 activation reverts oxidative stress and metabolic dysfunction associated to steatotic diseaseAndrea Morandi, Andrea Perra|Research Square|2024Cited by 0